# Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity

> **NCT05475431** · — · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 1053 (actual)

## Conditions studied

- Helicobacter Pylori Infection
- Comorbidities and Coexisting Conditions
- Real-world Outcome
- Medication Adherence
- Patient Compliance
- Patient Dropouts

## Interventions

- **DRUG:** The sequential therapy
- **DRUG:** The triple therapy
- **DRUG:** The hybrid therapy
- **DRUG:** The concomitant therapy
- **DRUG:** Bismuth-based quadruple therapy

## Key facts

- **NCT ID:** NCT05475431
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-06
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 1053 (ACTUAL)
- **Last updated:** 2024-11-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05475431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05475431, "Real-world Treatment of H. Pylori Eradication in Patients with Comorbidity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05475431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*